Resources with keywords: mmr
Measles (Rubeola): Lab Tools
CDC
includes speicmen collection, storage, shipment and serology practices for measles
Increase in Global and Domestic Measles Cases and Outbreaks: Ensure Children in the United States and Those Traveling Internationally 6 Months and Older are Current on MMR Vaccination
CDC Health Alert Network (HAN)
18 March 2024
Related to 58 confirmed cases of measles in US in 2024.
Manual for the Laboratory-based Surveillance of Measles, Rubella, and Congenital Rubella Syndrome
TechNet-21.org
1 June 2018
Chapter 3- Includes Safety procedures for incoming clinical samples.
Third edition, June 2018
Biosafety considerations for attenuated measles virus vectors used in virotherapy and vaccination
Human Vaccines & Immunotherapeutics
12 May 2016
Baldo A, Galanis E, Tangy F, Herman P.
The use of recombinant MV vector has to comply with various regulatory requirements, particularly relating to the assessment of potential risks for human health and the environment. The present article highlights the main characteristics of MV and recombinant MV vectors used for vaccination and virotherapy and discusses these features from a biosafety point of view.
